US30050E1055 - ADR
Fabrinet stock is falling on Wednesday after the company provided FN investors with a date for its upcoming earnings report.
Evotec stock is falling on Wednesday as EVO investors react to a lackluster 2024 revenue guidance in its 2023 earnings results.
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning!
/PRNewswire/ -- Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration...
Looking for stocks under $10? Here are seven great bargain picks that you can buy for less than $10 per share today.
Looking for bargains in the market right now? These three stocks could be set to double in coming months.
If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks.
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.
Mobileye stock is taking a beating on Thursday with investors in MBLY bemoaning the company's revenue outlook for the year.
Peloton stock is heading higher on Thursday as investors in PTON react to the company signing a new partnership with TikTok.
Evotec stock is falling on Thursday with heavy trading of EVO shares following the resignation of the company's CEO, Dr. Werner Lanthaler.
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!
Evotec and Owkin join forces in an A.I.-powered strategic partnership to advance drug development activities in oncology, immunology, and inflammation.
Evotec's partner, Zhejiang Jingxin Pharmaceutical, receives approval for insomnia treatment EVT201 in China, paving the way for further development and...
Evotec press release (EVO): 9M Adjusted EBITDA of €50.2M Revenues increased by 14% Y/Y to €580.1M
Evotec SE press release (EVO): 1H adjusted Group EBITDA totalled €26.1M (H1 2022: €33.6M).Revenue of €383.8M (+13.9% Y/Y).Outlook: Group revenues expected to be in a range of € 750 - 790...
Evotec (EVO) announced Tuesday Bristol Myers Squibb (BMY) entered into a licensing agreement under the companies' partnership on neurodegeneration. Read more here.